NIVF - Utang jangka dawa perusahaan NewGenIvf Corp

A stable talent pool of leading embryologists in Southeast Asia allows NewGenIvf Group Limited (NIVF) to grow profits by leveraging the demand for IVF and the implementation of digital reproductive solutions. This chart illustrates a market valuation of long-term liabilities at 0.01. NewGenIvf Group Limited (NIVF) is developing a closed-loop family planning assistance cycle, integrating high-tech laboratories with surrogacy services within a single Asian network.

NIVF (NewGenIvf) riwayat Utang jangka dawa perusahaan saka 05.04.2024 nganti 28.10.2026

High debt leverage increases the business vulnerability of NewGenIvf Group Limited (NIVF) to regulatory shocks and demand fluctuations in Southeast Asia. It is critical for NewGenIvf Group Limited to maintain a balance of liabilities amid liability risks in reproductive medicine. This metric aggregates all loans with maturities exceeding twelve months, reflecting the long-term financing strategy. An analysis of the organization's long-term financial debt allows for an assessment of the cost of borrowed capital and its service rates. While growth in this line signals expansion, excessive leverage could trigger a collapse in share prices.

Analisis pesaing

Utang jangka dawa HCA Inc. HCA|Tenet Healthcare Corporation - Utang jangka dawa perusahaan|Fresenius Medical Care AG (FMS) - Utang jangka dawa perusahaan|SOLV - Kewajiban jangka dawa perusahaan|EHC (Encompass) - Gedhene kewajiban jangka dawa|Utang jangka dawa perusahaan UHS|Kewajiban jangka dawa perusahaan davita.com|RadNet - Utang jangka dawa perusahaan|Utang jangka dawa OPCH (Option Care)|SGRY - Utang jangka dawa perusahaan|PINC - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan National Vision Holdings EYE|PGNY: Gedhene kewajiban jangka dawa|Utang jangka dawa perusahaan Ardent Health Partners|Select Medical Corporation (SEM) - Tanggungan utang jangka dawa perusahaan|Utang jangka dawa perusahaan ASTH (Apollo Medical Holdings)|Utang jangka dawa mednax.com (MD)|Kewajiban jangka dawa perusahaan USPH (U.S. Physical Therapy)|Kewajiban jangka dawa perusahaan pennantgroup.com (PNTG)|ORGO (Organogenesis) - Utang jangka dawa perusahaan|Tanggungan jangka dawa Nutex Health Inc NUTX|AUNA (Auna Health) - Utang jangka dawa perusahaan|SBC: Utang jangka dawa|Utang jangka dawa perusahaan Evolus, Inc.|chs.net (CYH) - Tanggungan utang jangka dawa perusahaan|SKIN: Utang jangka dawa perusahaan|Gunggunge utang jangka dawa MediWound, Ltd. (MDWD)|Kewajiban jangka dawa perusahaan Biote Corp (BTMD)|Utang jangka dawa perusahaan The Joint (JYNT)|DocGo Inc. (DCGO) - Utang jangka dawa perusahaan|PIII - Kewajiban jangka dawa|Kewajiban jangka dawa perusahaan Gain Therapeutics, Inc. (GANX)|EUDA - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan BMGL (baselmedical.com)|CLGN (CollPlant Biotechnologies Ltd.) - Tanggungan jangka dawa|CUPR - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan CCM|American Shared Hospital Services - Utang jangka dawa perusahaan|Utang jangka dawa MEDIROM Healthcare Group Inc. MRM|Kewajiban jangka dawa perusahaan ALBT (Avalon GloboCare Corp.)|DIH Group - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan Longevity Health Holdings|ATI Physical Therapy (ATIP) - Kewajiban jangka dawa|Kewajiban jangka dawa perusahaan CareMax CMAX|KDLY (Kindly MD Inc) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan LogistiCare|Utang jangka dawa perusahaan Novo Integrated Sciences Corp|SSY (SunLink Health Systems) - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa BACK (imacholdings.comm)